A PREVIOUS paper (Foulds, 1947) recorded the origin in hybrid mice of spontaneous mammary tumours, many of which were transplantable in female or oestrogenized male hosts but not in normal males. The present paper is concerned primarily with evidence for the prese-nee and transmission of the mammary tumour agent. Two succeeding papers (Foulds, 1949a, in the earher paper.
The prewnt investigations provide evidence for the presence of tumour agent in BR F , hybrids, although these mice were nursed by their C57 black mothers presumed deficient in tumour agent. They show that spontaneous mam iary tumours developed abundantly in the progeny of two tuinour-bearing BR F, females, and that extracts of a transplanted BR F 1 tumour induced the growth of mammary tumours in other hybrids deficient in the tumour agent. Further observations on BR F, hybcicls we xecorded, and a high incidence of tumours in the reciprocal RB F, hybrids is described. Finally it is shown that the incidence of tumours in BR F, hybrids is, greatly reduced or delayed when the male parent is derived from a line of R3 mice fi-eed from the tumour agent.
Mammary tunwurs in BR F., mice. Amongst the survivors of the BR F, colony described in the earher report (Foulds, 1947) " is the average age at which a t-umour was first detected, the mice being inspected twice weekly. The mice ahve with tumours include mice with nodules growing and regressmg m repeated cycles; as described by Foulds (1949b) , mice with these nodules almost always die with large typical tumours. Mice in which nodules were present at some period but not at the T"LE I.-Strain BR4 (Pink Labd).
Tumour-free.
Tumour-bearin,-. The incidence of tumours in the BR16 strain (Table IV) so far is extremely low. The great majority of the mice survive and more tumours may yet develop, but the average age is already higher than th'e average age of tumour development in the other three strains. Whatever the final incidence, the contrast between strain BR 1 6 -and strains BR4 (pink label), BR4 (blue label), and BR6 is unmistakable.
Mammary tumour agent in tran8planted BRI tumour8.
Extracts of transplaiited tumours of the hormone-dependent BR I strain (CRI in the previous report by Foulds (1947) ) were injected into female BA F, mice (C57 black x A According to previous experience in this laboratory (Gye, 1948) (1948, a, b, c) investigated the occurrence of tumours in mice with strain C (low-tumour) mothers and strain C3H (high-tumour) fathers. Their results, which corresponded in some respects with my observations on hybrids with C57 black (low-tumour) mothers and R3 (high-tumour) fathers but differed in other respects, are discussed in later paragraphs.
The incidence of tumours in BR F, hybrids (C57 black ? x R3 S) resembled that recorded by others for various hybrids with low-tumour strain mothers and high-tumour strain fathers. Although the incidence was not high the tumours appeared at an average age of 38 weeks, which was within the range of age incidences of tumours in high-tumour strains. The histological structure was unremarkable except in two tumours which developed near the sites of injection of a carcinogen and in one tumour in a virgin. The sex-limited transplantation described in a previous paper was not pecuhar to BR F 1 hybrids ; as recorded in the paper which follows (Foulds, 1949a) subhnes estabhshed by selective breeding. By contrast the tumour incidence in the progeny of a tumour-fi-ee BR F 1 female sired by a male that sired, also, one of the tumour strains was extremely low or extremely late. These results recaRed Bittner's (I940) observations on strain A mice nursed by C57 black foster-mothers. A minority (7-9 per cent) of the fostered A females developed mammary tumours, presumably because they received tumour ageDt from their strain A mothers before being transferred to foster-mothers, and the tumour incidence in their progeny was high (58-5 per cent). The majority of the fostered A mice developed no tumours and the incidence in their progeny was low (6-1 per cent).
In sum, the observations indicated that a minority of (C57 black x R3 F]L hybrid females carried and transmitted the mammary tumour agent and developed mammary tumours, whereas the majority of the mice did not carry or transmit the agent and did not develop tumours. Direct and indirect evidence for the presence of tumour agent in tumour-bearing hybrids limits discussion to the source of the agent and the reason for its uneven distribution amongst the F , hybrids.
The subhnes of C57 black mice maintained in various laboratories are not now identical and some possibly carry the mammary tumour agent, perhaps in attenuated or masked form. In this laboratory mammary tumours have not been recorded in the pedigreed stock although they have occurred, rarely, in unpedigreed mice derived from the C57 black stock as, for example, by random interbreeding; our subhne maintains therefore the essential characteristics of the original stock. Mamm ry tumours have developed in two types of hybrid with C57 black mothers, namely (C57 black x R3) F, and (C57 black x C3H) F, but not in a third type (C57 black x A) F, (Gye, 1948 , and this paper). Evidently the strain of the father had a subsUntia'l effect on the incidence of tumours in F IL hybri&-,. The patemal contribution was not probably genetic for, as shown in this paper and in previous reports from this laboratory (Dmochowski, 1944 (Dmochowski, , 1945 , the C57 black x A hybrids developed tumours abundantly when tumour agent was supphed to them artificiafly. The uncompleted observ-ations on hybrids having fathers belonging to a subline of R3 mice deprived of tumour agent accorded with similar observations bv Anderv-ont and Dinnn (1948a, b, c) (Dmochowski, 1946) , and by the high natural incidence now recorded in the reciprocal RB F, hybrids. The relatively low natural incidence of tumours in BR F 1 was attributed provisionally, therefore, to -the erratic transmission of tumour agent by male parents to their hybrid offspring. Andervont (1945b) and Andervont and.Dunn (1948a, b, c) studied the hybrid offspring of females of the strain C, having a mammary tumour incidence of less than I per cent, and males of the high-tumour strain C3H. Tumour 
